相似文献
1
Digitally deconvolving the tumor microenvironment.
Genome Biol. 2016 Aug 22;17(1):175. doi: 10.1186/s13059-016-1036-7.
2
Reprogramming the Tumor Microenvironment to Improve Immunotherapy: Emerging Strategies and Combination Therapies.
Am Soc Clin Oncol Educ Book. 2019 Jan;39:165-174. doi: 10.1200/EDBK_237987. Epub 2019 May 17.
3
Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade.
Clin Cancer Res. 2019 Mar 1;25(5):1612-1623. doi: 10.1158/1078-0432.CCR-18-1932. Epub 2018 Dec 11.
4
The Summit for Cancer Immunotherapy (Summit4CI), June 26-29, 2016 Halifax, Canada.
Cancer Immunol Immunother. 2017 Jun;66(6):811-818. doi: 10.1007/s00262-017-1996-9. Epub 2017 Apr 13.
5
Joining Forces: Improving Clinical Response to Cellular Immunotherapies with Small-Molecule Inhibitors.
Trends Mol Med. 2021 Jan;27(1):75-90. doi: 10.1016/j.molmed.2020.09.005. Epub 2020 Sep 30.
6
Anti-angiogenesis: Opening a new window for immunotherapy.
Life Sci. 2020 Oct 1;258:118163. doi: 10.1016/j.lfs.2020.118163. Epub 2020 Jul 29.
7
The Mechanism of Stimulating and Mobilizing the Immune System Enhancing the Anti-Tumor Immunity.
Front Immunol. 2021 Jun 10;12:682435. doi: 10.3389/fimmu.2021.682435. eCollection 2021.
8
The Role of Adaptive Immunity in the Efficacy of Targeted Cancer Therapies.
Trends Immunol. 2016 Feb;37(2):141-153. doi: 10.1016/j.it.2015.12.007. Epub 2016 Jan 7.
9
Harnessing tumor-associated macrophages as aids for cancer immunotherapy.
Mol Cancer. 2019 Dec 5;18(1):177. doi: 10.1186/s12943-019-1102-3.
10
Should we be combining local tumor therapies with immunotherapies as standard?
Future Oncol. 2017 Aug;13(18):1573-1575. doi: 10.2217/fon-2017-0150. Epub 2017 Aug 22.
引用本文的文献
1
Molecular classification of geriatric breast cancer displays distinct senescent subgroups of prognostic significance.
Mol Ther Nucleic Acids. 2024 Aug 15;35(4):102309. doi: 10.1016/j.omtn.2024.102309. eCollection 2024 Dec 10.
2
A bioinformatics approach to identify a disulfidptosis-related gene signature for prognostic implication in colon adenocarcinoma.
Sci Rep. 2023 Jul 31;13(1):12403. doi: 10.1038/s41598-023-39563-y.
3
Pan-Cancer Study of SHC-Adaptor Protein 1 (SHC1) as a Diagnostic, Prognostic and Immunological Biomarker in Human Cancer.
Front Genet. 2022 May 2;13:817118. doi: 10.3389/fgene.2022.817118. eCollection 2022.
4
Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas.
PLoS One. 2019 Dec 27;14(12):e0219724. doi: 10.1371/journal.pone.0219724. eCollection 2019.
5
New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx.
PLoS Comput Biol. 2019 Mar 5;15(3):e1006701. doi: 10.1371/journal.pcbi.1006701. eCollection 2019 Mar.
6
Exosomal miR-1228 From Cancer-Associated Fibroblasts Promotes Cell Migration and Invasion of Osteosarcoma by Directly Targeting SCAI.
Oncol Res. 2019 Sep 23;27(9):979-986. doi: 10.3727/096504018X15336368805108. Epub 2018 Aug 8.
7
Integrative analysis of the inter-tumoral heterogeneity of triple-negative breast cancer.
Sci Rep. 2018 Aug 7;8(1):11807. doi: 10.1038/s41598-018-29992-5.
8
Computational de novo discovery of distinguishing genes for biological processes and cell types in complex tissues.
PLoS One. 2018 Mar 1;13(3):e0193067. doi: 10.1371/journal.pone.0193067. eCollection 2018.
9
Estimation of immune cell content in tumour tissue using single-cell RNA-seq data.
Nat Commun. 2017 Dec 11;8(1):2032. doi: 10.1038/s41467-017-02289-3.
10
Data normalization considerations for digital tumor dissection.
Genome Biol. 2017 Jul 5;18(1):128. doi: 10.1186/s13059-017-1257-4.
本文引用的文献
1
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy.
Genome Biol. 2016 Aug 22;17(1):174. doi: 10.1186/s13059-016-1028-7.
2
Widespread parainflammation in human cancer.
Genome Biol. 2016 Jul 8;17(1):145. doi: 10.1186/s13059-016-0995-z.
3
High-throughput genomic profiling of tumor-infiltrating leukocytes.
Curr Opin Immunol. 2016 Aug;41:77-84. doi: 10.1016/j.coi.2016.06.006. Epub 2016 Jun 30.
4
Systematic pan-cancer analysis of tumour purity.
Nat Commun. 2015 Dec 4;6:8971. doi: 10.1038/ncomms9971.
5
The future of immune checkpoint therapy.
Science. 2015 Apr 3;348(6230):56-61. doi: 10.1126/science.aaa8172.
6
Robust enumeration of cell subsets from tissue expression profiles.
Nat Methods. 2015 May;12(5):453-7. doi: 10.1038/nmeth.3337. Epub 2015 Mar 30.
7
Accessories to the crime: functions of cells recruited to the tumor microenvironment.
Cancer Cell. 2012 Mar 20;21(3):309-22. doi: 10.1016/j.ccr.2012.02.022.
Zotero 插件